1.
|
Phase: Phase II Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: UCHSC-96309, NCI-T94-0171D, T94-0171
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UPCC-1694, NCI-T95-0010D, T95-0010
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCHSC-96-344, NCI-T95-0015H, T95-0015
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: NCI-2012-02239, MDA-DM-95061, NCI-T95-0035D, CDR0000064591, T95-0035, NCT00002725
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MDA-DM-95166, NCI-T95-0085H, T95-0085
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065272, P30CA022453, WSU-C-1257, WSU-D-1257, NCI-T95-0062D, T95-0062, NCT00002907
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065273, P30CA022453, WSU-C-1256, WSU-D-1256, NCI-T95-0058D, T95-0058, NCT00002908
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CRC-PHASE-II-PH2/031
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MDA-NCNSC-96213, NABTC-NCNSC-96213, NCI-T96-0080, T96-0080
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: DFCI-96278, NCI-T96-0112, T96-0112
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: Protocol IDs: CAN-NCIC-IND104, NCI-T96-0089, T96-0089, IND104
|
|
12.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSGCC-9711, NCI-T97-0037, T97-0037
|
|
13.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065975, P30CA022453, WSU-D-1468, NCI-T97-0047, T97-0047, NCT00003171
|
|
14.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-9070, NCI-T97-0075, T97-0075
|
|
15.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-9069, NCI-T97-0076, T97-0076
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: OSU-9801, NCI-T-97-0070, T97-0070
|
|
17.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 97-0751, UCHSC-97751, NCI-T97-0063, T97-0063, NCT00003205
|
|
18.
|
Phase: Phase II Type: Treatment Status: Completed Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000066081, P30CA022453, WSU-D-1457, NCI-T97-0065, T97-0065, NCT00003220
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-146H
|
|
20.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-127N
|
|
21.
|
Phase: Phase II Type: Treatment Status: Completed Age: Over 16 Sponsor: NCI Protocol IDs: MDA-DM-97253, NCI-T97-0093, T97-0093
|
|
22.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-98020607, NCI-T97-0074, T97-0074
|
|
23.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98042, NCI-T97-0095, NCT00003443, T97-0095
|
|
24.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067128, WSU-C-1902, NCI-T97-0120, T97-0120, NCT00003936
|
|
25.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02303, FCCC-99012, NCI-T99-0002, CDR0000067169, T99-0002, NCT00003968
|